Technical Analysis for BPMX - BioPharmX Corporation

Grade Last Price % Change Price Change
grade D 0.144 22.87% 0.03
BPMX closed up 22.87 percent on Tuesday, March 19, 2019, on 10.77 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical BPMX trend table...

Date Alert Name Type % Chg
Mar 19 200 DMA Resistance Bearish 0.00%
Mar 19 MACD Bullish Centerline Cross Bullish 0.00%
Mar 19 Expansion Breakout Bullish Swing Setup 0.00%
Mar 19 Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Mar 19 Pocket Pivot Bullish Swing Setup 0.00%
Mar 19 Volume Surge Other 0.00%
Mar 19 Wide Range Bar Range Expansion 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Above Upper BB Strength 0.00%
Mar 19 Gapped Up Strength 0.00%

Older signals for BPMX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The company's clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician's practices, including OB-Gyn's, dermatologists, and general practioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.
Chemistry Health Pharmaceutical Retail Customers Pharmacology Breast Cancer Acne Drug Delivery Dietary Supplement Over The Counter Drug Dermatology Topical Medication
Is BPMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.305
52 Week Low 0.05
Average Volume 5,571,500
200-Day Moving Average 0.1648
50-Day Moving Average 0.1092
20-Day Moving Average 0.1051
10-Day Moving Average 0.1064
Average True Range 0.0133
ADX 17.78
+DI 51.8138
-DI 10.3952
Chandelier Exit (Long, 3 ATRs ) 0.1386
Chandelier Exit (Short, 3 ATRs ) 0.1299
Upper Bollinger Band 0.1257
Lower Bollinger Band 0.0845
Percent B (%b) 1.44
BandWidth 39.200761
MACD Line 0.0029
MACD Signal Line -0.0009
MACD Histogram 0.0038
Fundamentals Value
Market Cap 11.47 Million
Num Shares 79.7 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -0.46
Price-to-Sales 185.99
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.23
Resistance 3 (R3) 0.23 0.21 0.22
Resistance 2 (R2) 0.21 0.18 0.20 0.21
Resistance 1 (R1) 0.17 0.17 0.19 0.17 0.21
Pivot Point 0.15 0.15 0.16 0.15 0.15
Support 1 (S1) 0.12 0.13 0.13 0.11 0.08
Support 2 (S2) 0.09 0.11 0.09 0.08
Support 3 (S3) 0.06 0.09 0.07
Support 4 (S4) 0.06